Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Preventive Ophthalmics appears to have been a small private ophthalmic diagnostics company focused on technologies for measuring retinal or visual pathway function. Publicly visible evidence centers on patent filings assigned to the company, particularly systems and methods for testing retinal function using optokinetic nystagmus-based visual stimuli. The available record suggests a device-oriented business rather than a therapeutic drug developer, with no clear evidence of active clinical programs, commercial products, substantial operations, or recent company activity. Corporate registry entries indicate the company was formed in 2010 in Delaware and California, but current operating status is unclear to inactive based on the lack of recent footprint and registry signals. Overall, Preventive Ophthalmics is best characterized as a defunct or dormant ophthalmic diagnostics startup with a very narrow known pipeline centered on retinal testing technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Preventive Ophthalmics.